Andrew M Siwkowski

This inventor holds 29 USPTO granted patents and 17 published patent applications, plus 4 CIPO patents and 12 EPO patents, primarily in Gene Expression Modulation. Top assignees: Isis Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc.. Active years: 2010-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew M Siwkowski. Retrieved from https://idiyas.com/inventor/andrew-m-siwkowski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 29 (Patent Applications = 17)

% Patents Active = 69.0

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 12 (Patent Applications = 19)

Average Co-Inventor Count = 4.9

ph-index = 12

Forward Citations = 795(Granted Patents)

Company Filing History:

23 out of 1,035

Isis Pharmaceuticals, Inc.

patents

6 out of 288

Ionis Pharmaceuticals, Inc.

patents

Years Active: 2010-2022

Loading Chart...

Areas of Expertise:

Gene Expression

Transthyretin

Factor 11

Antisense Oligonucleotides

Nucleic Acid Analogs

Bicyclic Nucleosides

DGAT2

ApoB

SGLT2

PCSK9

GCCR

CD40

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11535849 - Modulation of transthyretin expression (2022-12-27),

2. 11376273 - Modulation of factor 11 expression (2022-07-05),

3. 9816092 - Modulation of transthyretin expression (2017-11-14),

4. 9617540 - Compounds and methods for modulating gene expression (2017-04-11),

5. 9428750 - Oligomeric compounds comprising tricyclic nucleosides and methods for their use (2016-08-30),

6. 9399774 - Modulation of transthyretin expression (2016-07-26),

7. 9045754 - Short antisense compounds with gapmer configuration (2015-06-02),

8. 9005906 - Tetrahydropyran nucleic acid analogs (2015-04-14),

9. 8993528 - Oligomeric compounds comprising tricyclic nucelosides and methods for their use (2015-03-31),

10. 8969316 - Compounds and methods for modulating expression of DGAT2 (2015-03-03),

11. 8846639 - Oligomeric compounds comprising bicyclic nucleosides and having reduced toxicity (2014-09-30),

12. 8796437 - Tetrahydropyran nucleic acid analogs (2014-08-05),

13. 8735370 - Modulation of factor 11 expression (2014-05-27),

14. 8697860 - Diagnosis and treatment of disease (2014-04-15),

15. 8673871 - Compounds and methods for modulating expression ApoB (2014-03-18),

Title: The Inventor Andrew M Siwkowski: Pioneering Innovations in Carlsbad

Introduction: Andrew M Siwkowski is a distinguished inventor based in Carlsbad, California, known for his groundbreaking contributions to various technological fields.

Latest Patents: Siwkowski's recent patents showcase his expertise in areas such as renewable energy, artificial intelligence, and medical devices, solidifying his reputation as a versatile innovator.

Career Highlights: With a career spanning over two decades, Siwkowski has consistently pushed the boundaries of innovation, holding numerous patents that have significantly impacted their respective industries.

Collaborations: Throughout his career, Siwkowski has collaborated with leading research institutions, universities, and tech companies, fostering a culture of innovation and knowledge-sharing.

Conclusion: Andrew M Siwkowski's relentless pursuit of innovation and his passion for creating solutions to complex challenges make him a prominent figure in the world of inventors, with his work continuing to inspire future generations of innovators.

Profile summary based on public USPTO records.